Test Code MTX METHOTREXATE
Methodology
Homogeneous enzyme immunoassay
Useful For
Following therapy, serum concentration is used to judge whether the drug is being cleared appropriately and verify that a nontoxic concentration has been attained. Methotrexate has the potential for serious toxicity. Patients undergoing methotrexate therapy are closely monitored so that toxic effects are detected promptly.
Methotrexate (MTX) is an antineoplastic agent that inhibits DNA synthesis. High-dose MTX is used in the treatment of certain malignancies including leptomeningeal metastases, non-Hodgkin lymphoma, acute lymphoblastic leukemia and osteosarcoma, lung and breast cancer. Low-dose MTX is commonly used in the treatment of various nonmalignant disorders including rheumatoid arthritis (RA), psoriasis and ectopic pregnancies.
Specimen Requirements
Preferred:
Specimen Type: Serum
Container/Type: Serum Gel Tube
Specimen Volume: 0.5 mL serum (minimum 0.25 mL)
Alternate: Serum, Plain red-top tube
Lithium or Sodium Heparin Plasma, Green-top gel tube
EDTA plasma, Lavender-top tube
Collection Instructions:
- The sampling time of methotrexate is dependent on dose and duration of infusion. High-dose methotrexate therapy is typically monitored at 24 hours, 48 hours, and 72 hours post dose. Collect samples at times specified by the physician.
- Centrifuge specimen within 2 hours of draw.
- Protect specimen from light during transport and until analysis.
CAUTION: Specimens from patients who have received glucarpidase (carboxypeptidase G2) as a high-dose rescue therapy should not be tested with this assay. Methotrexate concentrations from patients receiving glucarpidase treatment should be performed using a LC-MS-MS method to avoid the reporting of falsely elevated methotrexate values. After glucarpidase therapy, it can take at least 5 to 7 days before accurate measurements of serum methotrexate can be obtained using an immunoassay method.
Day(s) Test Set Up
Monday through Sunday
Specimen Stability
Refrigerated
Reference Values
< 0.10 µmol/L 72 hours after dose
Performing Laboratory
Logan Health Medical Center Laboratory
Test Classification and CPT Coding
80299